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Abstract
The light-activated proton-pumping bacteriorhodopsin and chloride ion-pumping halorhodopsin are compared. They
belong to the family of retinal proteins, with 25% amino acid sequence homology. Both proteins have seven K helices across
the membrane, surrounding the retinal binding pocket. Photoexcitation of all-trans retinal leads to ion transporting
photocycles, which exhibit great similarities in the two proteins, despite the differences in the ion transported. The spectra of
the K, L, N and O intermediates, calculated using time-resolved spectroscopic measurements, are very similar in both
proteins. The absorption kinetic measurements reveal that the chloride ion transporting photocycle of halorhodopsin does
not have intermediate M characteristic for deprotonated Schiff base, and intermediate L dominates the process. Energetically
the photocycle of bacteriorhodopsin is driven mostly by the decrease of the entropic energy, while the photocycle of
halorhodopsin is enthalpy-driven. The ion transporting steps were characterized by the electrogenicity of the intermediates,
calculated from the photoinduced transient electric signal measurements. The function of both proteins could be described
with the ‘local access’ model developed for bacteriorhodopsin. In the framework of this model it is easy to understand how
bacteriorhodopsin can be converted into a chloride pump, and halorhodopsin into a proton pump, by changing the ion
specificity with added ions or site-directed mutagenesis. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Living cells preserve their functions, particularly in
very harsh environments, by building up and main-
taining ion gradients across their cell and organelle
membranes. The ions are driven across these mem-
branes by active pumps that use chemical or light
energy. Many of these pumps are complex multi-sub-
unit proteins. The ion pumps, which make use of the
light-driven bond rotation in retinal, and the confor-
mational changes in the protein that follow, in order
to change the accessibility of the transported ion be-
tween the two sides of a membrane, are the simplest
of such membrane-spanning proteins.
About 30 years ago, a light-driven proton pump,
bacteriorhodopsin (BR), was discovered in Halobac-
terium salinarum [1]. In this organism, the purple
membrane, a part of the cell membrane, contains
only BR in a highly ordered two-dimensional hexag-
onal crystalline form [2]. Several years later, another
ion pump, salinarum halorhodopsin (sHR or HR in
general) was discovered in the same organism,
though present in a much lower concentration [3].
HR was initially considered to be a light-activated
sodium pump [4^6], but was later shown to transport
chloride ion through the membrane [7]. Natronobac-
terium pharaonis was found to contain a very similar
light-activated chloride pump, pharaonis halorho-
dopsin (pHR) [8,9].
BR and both HRs are integral membrane proteins,
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with seven transmembrane helices enclosing a bind-
ing pocket of the chromophore [10,11]. The light-
sensitive chromophore in all rhodopsin-type proteins,
i.e., the two kinds of ion pumps, the sensory rhodop-
sins and the visual rhodopsins of higher organisms, is
a retinal bound to a lysine via a protonated Schi¡
base. In the ion-pumping rhodopsins, the retinal in
the protein binding pocket is in a thermal equilibri-
um between the all-trans,15-anti and 13-cis,15-syn
con¢gurations [12^14], when the protein is dark-
adapted.
The natural two-dimensional crystalline arrange-
ment of BR in the purple membrane had great ad-
vantages for determination of the structure of the
protein [2], but only recently was a structure with
resolution as high as 1.55 Aî published [15]. The over-
all three-dimensional structure of sHR exhibits great
similarity to that of BR, although the details are not
yet known because at the time of this writing the best
resolution achieved is only 6 Aî , and there is only a
projection map [11].
Illumination of the ion-pumping rhodopsins ini-
tiates a multistep reaction cycle in both retinal iso-
mers. The 13-cis photocycle has two intermediates
[16,17], and under physiological conditions is without
ion transport activity. The all-trans retinal-contain-
ing protein proceeds through a series of thermal
steps, and this is the process that transports the ion
across the membrane [17^21].
Through the use of a large variety of spectroscopic
methods, such as fast and ultrafast laser spectrosco-
py, resonance Raman, kinetic and static Fourier
transform infrared (FTIR), nuclear magnetic reso-
nance, etc. on wild-type and mutant BR, the confor-
mational changes in the retinal and protein have
been described in detail (for reviews see [22^25]).
The time course of proton transport through the
membrane and its release and uptake steps have
also been thoroughly studied [26^29]. The same
methods have also been applied to HR, but less in-
formation has accumulated [19,30^34]. The purpose
of this review is to compare the available informa-
tion, and to point out the similarities and di¡erences
between the proton-pumping BR and the chloride
ion-pumping HR. For additional information on
these pump rhodopsins, the reader is referred to
the articles in this issue and to other recent reviews
[23^25,35^37].
2. Structure
2.1. Amino acid sequence
The amino acid sequence of BR, determined in
1979, was the ¢rst primary structure for an integral
membrane protein [38,39]. The protein contains 248
residues (molecular weight about 26 kDa) and a ret-
inal covalently bound to Lys-216. The predominance
of K helices in the secondary structure of the protein
was deduced from the hydrophobicity of the se-
quence and con¢rmed by low-resolution electron dif-
fraction [2]. The protein consists, in fact, mainly of
seven K helices, each spanning the membrane, and
only short extramembrane segments [38^40].
The primary structures of sHR [41] and pHR [42]
were determined from their gene sequence. The se-
quence identities reveal a homology of about 25%
between the two HRs and BR, with a greater con-
servation in the transmembrane part (36%) and less
in the loops (19%) [41]. On the same basis, the extent
of sequence identity between the two HR molecules
is much higher (66%). In BR, helix C holds the pro-
ton acceptor group (Asp-85) and the donor group
(Asp-96); both are replaced in HR with neutral res-
idues (Fig. 1). On the extracellular side, there is a
proton release complex in BR (Arg-82, Glu-194,
Glu-204 and several bound water molecules); this
complex is perturbed in HR because of the replace-
ment of Glu-204 by Thr.
In sHR and pHR, helices C and F display the
highest similarity; but while in helix F there are sev-
eral conservative replacements, in helix C apart from
two surface amino acids, the sequence is identical
(Fig. 1). There are several highly conserved amino
acids, such as Asp-212 in BR (position 238 in sHR
and position 252 in pHR) and Arg-82 (position 108
in sHR and position 123 in pHR). They form a
counterion complex and stabilize the protonated
Schi¡ base [43^46]. Some other Arg, Thr and Ser
are also conserved [47].
The role of arginines in the chloride transporting
process of HR was investigated, because it could
have an important role in chloride ion binding
[47,48]. Indeed, the Arg mentioned above (at position
108 in sHR and position 123 in pHR) plays an im-
portant role in the chloride-pumping activity. Its re-
placement by a neutral residue inactivates the chlo-
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ride pump [47,49]. The single conserved histidine in
HR, which is missing from BR, is also considered
important in the chloride-pumping activity of these
proteins [32,50].
2.2. Protein structure
The two-dimensional crystalline arrangement of
BR in the purple membrane was an obvious and
very promising object for electron di¡raction study
[51], but the lack of information on the third dimen-
sion was a strongly limiting factor, overcome parti-
ally by measurements with tilted samples. The intro-
duction of cryo-microscopy improved the 7 Aî
resolution to 3.5 Aî [10,52]. The location of the reti-
nal was determined to be between the K helical seg-
ments [53]. Recently, a new crystallization method
was introduced: the growth of highly ordered
three-dimensional microcrystals in a cubic lipid
phase [54]. The new developments have resulted in
higher resolutions [54^56], leading most recently to a
1.55 Aî resolution structure for BR [15]. In this struc-
ture the positions of the bound water molecules are
identi¢ed and the H-bonded network in the extracel-
lular half-channel revealed, which plays important
roles in proton release to the extracellular surface
during the photocycle, and in the later photocycle
step that constitutes proton conduction from Asp-
85 to the proton release group.
In wild-type H. salinarum, HR does not form pur-
ple membrane patches, but two-dimensional crystal-
line patches appear in the cell membrane of a mu-
tated overproducing strain D2 [57]. This led to the
determination of the structure at 6 Aî resolution
[11,57]. The projection map shows that the seven K
helices have an arrangement similar to that in BR.
The most important di¡erence at this resolution is
that the side chain volumes in the cytoplasmic half-
channel are smaller than those for BR [11], and the
intramolecular space between helices B, C, F, and G
is larger. It was suggested that the ¢rst of these dif-
ferences corresponds to the di¡erence in function,
namely that the transported chloride ions are larger
than the protons.
Conformational changes in the protein during the
photocycle can be followed by di¡erent methods,
such as time-resolved linear dichroism [58], circular
dichroism [59], optoacoustic [60], kinetic FTIR [61]
or thermodynamic measurements [62], but none of
these techniques provides speci¢c molecular informa-
tion about the location of the changes. The exact
structural changes may be followed by low-temper-
ature trapping and di¡raction study of the intermedi-
ates. For BR these studies have already yielded
promising results on intermediates K [63] and M
[64,65]. No such studies have yet been reported
with HR.
2.3. Retinal con¢guration
The retinal in visual rhodopsins is in the 11-cis
form, but in the bacterial rhodopsins it is in the
all-trans,15-anti, or 13-cis,15-syn con¢guration.
Dark-adapted BR contains about 35% all-trans
[14]. During sustained light adaptation, the all-trans
retinal content increases to almost 100% [12,66].
Light adaptation has signi¢cant practical consequen-
ces for studying the photocycle, as the light-adapted
sample becomes homogeneous in the retinal con¢g-
uration.
The retinal in sHR in the dark-adapted state is
45% all-trans and 55% 13-cis. Sustained light adap-
tation shifts this equilibrium to a maximum of 75%
all-trans content in sodium chloride, which means
that a homogeneous sample can never be achieved,
and only this 75% has ion-pumping activity [17]. In
sodium sulfate there is no light adaptation; in both
the dark- and the light-adapted forms, the all-trans
content of the sample is about 67% [34]. In pHR the
all-trans content of the preparation is constant at
85% under all conditions (di¡erent salts and illumi-
Fig. 1. Two segments from the aligned protein sequences for
BR, sHR and pHR [42].
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nation) [21,34]. Although the sample is not homoge-
neous, there is no evidence that the 13-cis-containing
pHR is photoactive or takes part in the chloride-
pumping process [21].
3. Ion binding
It has long been known that on titration with acid
in the absence of chloride, the spectrum of BR shifts
towards the red (the membranes change from purple
to blue, the ‘acid blue’ form) through several inter-
mediate states. On lowering of the pH in the presence
of chloride, instead of the ‘acid blue’ form an ‘acid
purple’ form is obtained [67^69]. Under physiological
conditions, between pH 4 and 9, BR undergoes no
spectral change and no important amino acid ti-
trates. At above pH 9, a slight blue shift in the spec-
trum is observed. This complex pH titration of BR is
explained by the fact that a complex of the proton
acceptor Asp-85 and the proton release group that
includes Glu-204 displays two pKa values, a main
transition at 2.6 and a secondary transition at 9.7
[70^74]. At low pH, the acid blue to acid purple
transition suggests two chloride binding constants
of 0.1 M and 1.3 M, each for one ion [68].
HR is more a¡ected at high pH than BR. Under
alkaline conditions, a yellow form appears, with a
pKa strongly dependent on the presence of sodium
chloride or other salts in the solution [19,75]. The
spectral data at lower pH gave a chloride binding
constant of 10 mM for sHR; although the spectra
are only slightly shifted, their amplitude changes ap-
preciably [75^78]. The chloride-dependent spectral
changes in pHR are greater. With increasing chloride
concentration, the spectrum shifts by about 13 nm
towards the blue and its amplitude increases [19,21],
revealing a binding constant of 1 mM. This change
in color is similar to that of the acid purple to acid
blue transition in BR. FTIR and Raman spectrosco-
py indicate an interaction between the protonated
Schi¡ base and the halide ion, predicting a chromo-
phore^anion interaction [79,80]. A similar spectral
shift was observed for the D85T BR mutant, which
converts BR to a chloride pump [81]. Another inter-
esting observation on pHR is its azide-dependent
spectral shift. Increasing azide concentration in a
chloride-free preparation causes the same spectral
change as observed for chloride, but with a binding
constant of 10 mM azide. Thus, azide is bound as an
anion like chloride. Indeed these two ions compete
for the same binding site [82].
4. Photocycle
Ion translocation during the photocycle involves a
series of thermal reactions, initiated by the absorp-
tion of a photon. This cycle has been investigated by
a wide variety of techniques; the most frequently
used being real-time transient spectroscopy. Many
photocycle models have been discussed, from the
simplest, with a unidirectional reaction between the
intermediates [83], to more complicated ones with
reversible reactions, and parallel or branching photo-
cycles [84^86]. The aim of this review is not to dis-
cuss all such models in detail. For additional infor-
mation, the reader is referred to other papers in the
present issue and to reviews [23^25,35^37].
4.1. The 13-cis photocycle
Although the absorption changes from the photo-
cycle of the 13-cis retinal-containing protein are
measured together with those from the all-trans pho-
tocycle, they can be separated mathematically by us-
ing two sets of measurements in which the all-trans
to 13-cis ratio is changed. For both BR and sHR,
this procedure led to a rather simple photocycle with
one or two red-shifted intermediates, and the initial
state recovers with multiexponential kinetics
[16,17,87,88]. During the 13-cis photocycle, at neutral
pH, charge motions may be measured inside the pro-
tein, but without a net charge transport across the
membrane, proving that this cycle is not associated
with a transport process [16]. On the other hand, at
alkaline pH in the 13-cis photocycle the presence of
intermediate M was observed and proton transport
activity was measured [89,90].
In addition to these photocycles, which begin and
end with the 13-cis state, both proteins undergo light
adaptation. Light adaptation has been presumed to
occur through an independent process, with very low
quantum e⁄ciency. In BR this has been estimated to
be 0.035 [16,87]. In HR, even very long light adap-
tation cannot totally convert the 13-cis retinal con-
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¢guration to the all-trans : 25% always remains in the
13-cis con¢guration. Two possible explanations ex-
ist : either the thermal dark adaptation is fast, or a
small portion of the all-trans retinal is also photo-
actively converted to 13-cis. After the light is o¡, the
dark adaptation takes several hours, which makes
the ¢rst explanation unlikely. There is one indirect
feature that lends support to the second assumption:
the wavelength dependence of the light adaptation
[34].
4.2. The all-trans photocycle
4.2.1. Spectra of intermediates
The spectral characterization of the photocycle in-
termediates was initially performed by accumulating
the intermediate states at low temperature [91^93].
The introduction of fast spectroscopic techniques,
such as use of the optical multichannel analyzer,
made it possible to determine the spectra by using
real-time measurements at ambient temperature
[94,95]. The development of the mathematical meth-
ods facilitated the accurate determination of the
spectra of the BR intermediates (Fig. 2A), and they
were demonstrated to be independent of pH in the
pH range 4^9 [96].
Spectral calculations were carried out also for HR,
by a similar technique as for BR (Fig. 2B) [17,21].
Presumably for kinetic reasons, in the photocycle of
sHR the O intermediate does not accumulate. A red-
shifted intermediate, which was long considered to be
O, was shown to belong to the 13-cis photocycle [17].
The two spectral sets for sHR and pHR halorhodop-
sin intermediates are almost identical, and they ex-
hibit great similarity with the spectra of the inter-
mediates calculated for BR (Fig. 2). The major
di¡erence is that the strongly blue-shifted M state
is missing from the spectra of HR intermediates.
The Schi¡ base cannot deprotonate, because the pro-
ton acceptor is missing [41,42]. As will be shown
below, if the proton acceptor is replaced, the chloride
pump can be converted to a proton pump.
4.2.2. Kinetics
From the large number of mathematically possible
models, containing all the possible pathways between
the intermediates, only those were considered which
did not contradict other experimental facts. In this
review only the most widely accepted model is pre-
sented, the sequential model with reversible reac-
tions, which presents a number of common features
in the studied ion pumps (Fig. 3). The reader inter-
ested in the di¡erent models is referred to appropri-
ate reviews [20,22,24].
The red-shifted intermediate K with a 13-cis,15-
anti retinal con¢guration appears in several picosec-
onds after the photoexcitation [97]. The all-trans to
13-cis isomerization that causes a con£ict between
the retinal and its binding site captures the photon
energy necessary to transport the ion through the
membrane. The stress induced by the isomerization
is thermally relaxed as the protein converts to the
blue-shifted intermediate L [98]. The next step in
the BR is the L to M transition, i.e., the transfer
of the proton from the Schi¡ base to the proton ac-
ceptor Asp-85 [99,100].
In BR, re¢nement of the sequential model has led
to the introduction of ‘silent’ intermediates. These
are spectrally indistinguishable substates that di¡er
from one another in some properties of the protein.
The most important ‘silent transition’ is the M1 to
M2 transition (Fig. 3, BR cycle), when the protein
switches between the extracellular and cytoplasmic
conformations, after deprotonation of the Schi¡
base [101^103]. There are special conditions, such
as solubilization or mutation, when the spectra ofFig. 2. Spectra of photocycle intermediates for BR and pHR.
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M1 and M2 di¡er slightly [104,105]. The Schi¡ base
is reprotonated by the proton donor Asp-96 on the
cytoplasmic side [100], re£ected by the appearance of
intermediate N, followed by the uptake of the proton
from the surrounding medium. When the retinal iso-
merizes back to all-trans, the red-shifted intermediate
O appears and the protein relaxes back to the initial
BR state.
The Schi¡ base in HR cannot deprotonate, be-
cause the proton acceptor Asp is replaced by a neu-
tral Thr [41,42]. The intermediate L has a very long
lifetime (Fig. 3, HR cycle), followed directly by N. In
pHR the next intermediate is O, followed by a silent
intermediate HRP (evident only from an additional
time constant), with the same spectrum as that of the
unphotolysed HR [21].
The thermodynamic study of the two proteins
yielded interesting details concerning the energetic
features of the ion transport [33,62,106]. Apart
from the last step, when the protein returns to the
initial state, almost all the transitions proceed with
little change in free energy, i.e., the reactions are
close to equilibrium. In BR at pH above 6, the M1
to M2 transition becomes unidirectional. The free
energy level of M2 decreases relative to that of M1,
ensuring the unidirectionality of the proton transport
even at very low proton concentration. Some transi-
tions are strongly entropy-driven, with a rather large
entropy increase [62]. For the M1 to M2 transition,
the dependence on hydrostatic pressure suggested an
approximate volume increase of 32 ml/mol [107]; this
was attributed to the conformational change during
the opening of the cytoplasmic side. In HR all reac-
tions are enthalpy-driven, accompanied by a step by
step entropy decrease, i.e., the intermediates are
more highly ordered [33]. During the L to N transi-
tion in HR, a volume decrease of approximately 60
ml/mol was observed [33], suggesting that in this step
HR closes the cytoplasmic space observed in the
structure [11].
4.2.3. Electrogenicity
The ion translocation through the membrane is
accompanied by an electric signal, which re£ects
charge rearrangements perpendicular to the mem-
brane surface. The electric signals measured for dif-
ferent BR-containing oriented purple membrane sys-
tems demonstrated a remarkably good correlation
with the photocycle [26,27,108]. In principle, the elec-
tric dipole moment of each intermediate will be a
function of the charge con¢guration in the protein,
which depends on the positions of the amino acid
side chains and the transported ion. It was found
that each intermediate had a well-determined electro-
genicity, which expressed the change in its electric
dipole moment relative to that of the unexcited pro-
tein [28,29]. A new sample preparation and measur-
ing technique made it possible to solve the three-di-
mensional motion of the charges [109]. Apart from
intermediate N, the calculated electrogenicities in BR
were pH-independent, re£ecting that in the pH range
4^9 no amino acid side chain that takes part in the
proton transport was titrated, suggesting that the
charge motions occur inside the protein.
Oriented samples of HR were also prepared and
their electric signals were measured [30,110^112]. Ka-
laidzidis and co-workers could not correlate the slow
part of the electric signals of pHR with the late pho-
Fig. 3. Photocycle of BR and HR. The wavelengths of the absorption maxima are as indicated.
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tocycle intermediates [111]. A parallel measurement
of electric signals and absorption kinetics proved the
correlation and the electrogenicities of all intermedi-
ates were calculated [112]. In both forms of ion-
pumping rhodopsins, the electrogenicity of inter-
mediate K is negative, and re£ects the isomerization
of the retinal. Whereas in BR the intermediate L has
also negative electrogenicity, in HR it is positive. All
the other intermediates have positive electrogenicity,
re£ecting the general direction of charge transport
(Table 1) [29,112].
5. Ion transport
The mechanism of ion transport could be deduced
from the accumulated data, and a general transport
model could be derived. The transport functions of
retinal proteins have been described in terms of two
di¡erent conceptual frameworks: the IST and the
local access models.
The IST model simpli¢es the transport process to
a combination of three basic events (isomerization/
switch/transfer) [47,113]. The observed variety of
transport modes in the D85N mutant of BR, in
HR, and in sensory rhodopsins is explained by var-
ious sequences of these events. The fact that the se-
quence of the steps is not invariable leads to the
interesting conclusion that their driving force is es-
tablished in the ¢rst step of the cycle (photoisomeri-
zation), and they are therefore in kinetic competition
with one another. It is indeed tempting to describe
the transport in terms of three basic events, which
are logical components of a light-activated transport.
The IST model does not intend to describe the details
of the mechanism of the ion transport steps.
The local access model concentrates more on the
process and is designed to seek the basic rules that
govern the light-activated ion transport [114,115]. It
is meant, nevertheless, to account for the same data
as the IST model, as well as more recent spectroscop-
ic information [114]. In BR, the proton-transporting
photocycle of the all-trans,15-anti isomeric form,
after photoisomerization of the retinal in 13-cis,15-
anti, in the L, M and N states the protein oscillates
between extracellular (EC) and cytoplasmic (CP)
con¢gurations. In intermediate L, due to changes in
the pKa of the proton acceptor Asp-85, the proton is
transferred toward the EC side, giving rise to M. M1
is the EC, and M2 the CP con¢guration of the pro-
tein. In M2, the proton is transferred from the pro-
ton donor Asp-96 to the Schi¡ base, producing in-
termediate N. The change in accessibility from EC to
CP is accompanied by a volume increase (measured
by thermodynamic methods [107]), meaning that the
CP conformation has the larger volume. In the ¢nal
steps, going through O to BR, the retinal regains its
all-trans,15-anti con¢guration and the protein once
again has its original conformation. During the pho-
tocycle, the changing proton a⁄nities of the proton
acceptor and donor, modulated by the £uctuation of
the local geometry and the accessibility of the en-
trance of EC and CP half-channel, determine the
direction of proton transport [115]. The switch,
therefore, is not associated with a single event of
the photocycle. Also unlike the IST model is the
fact that in the local access model the photocycle is
a cascade, in which each step is the direct cause of
the step that follows it.
Although data are not yet su⁄cient for a detailed
mechanism of chloride transport in HR, a tentative
model can be elaborated on the basis of the same
local access model. The transported ion is negatively
charged, and the transport in the cell is inward. In
the unphotolysed state, the chloride binding site is
accessible on the EC side, but with a protein struc-
ture with a larger unit cell volume as compared to
BR [11]. After photoexcitation, during the K to L
transition the retinal is driven to a relaxed 13-cis
form, which results in the protein £ickering between
two conformations. The retinal con¢guration and the
£uctuation of the protein lead to changes in the ac-
cessibility and the a⁄nity of the binding site [79].
When the photocycle reaches intermediate N, in the
Table 1












G. Va¤ro¤ / Biochimica et Biophysica Acta 1460 (2000) 220^229226
CP conformation the binding constant of the site
becomes low, and the chloride is released. The reiso-
merization of the retinal to the all-trans form drives
the protein through intermediate O, in the EC con-
formation. On the uptake of a chloride, intermediate
HRP appears, the excess energy is lost and the pro-
tein returns to its unexcited HR state. The CP con-
formation of the protein has a smaller volume com-
pared to EC; this is re£ected in a volume decrease
during the L to N transition of the photocycle [33].
6. Interconversions of BR and HR
The great similarity between the two ion pumps
raises the possibility of converting BR to a chloride
pump or HR to a proton pump. There are two ways
to change the ion speci¢city of the protein.
(a) With added ions. In the case of BR, the proton
acceptor is neutralized at acid pH. Asp-85 has a very
low pKa of about 2.6 [70,71]. In this case, at pH
about 2, but without chloride ion present, the spec-
trum of BR is red-shifted (acid blue form). When
chloride is added, the spectrum shifts back (acid pur-
ple form). With quasi-continuous and continuous il-
lumination it has been shown that the acid purple
form, but not the acid blue form, performs transport
through the membrane. Changing the halide ion, the
transport activity can be changed. In contrast, when
protons are replaced by deuterons, no change in
transport activity is measured. These observations
led to the conclusion that in the acid purple form
BR transports chloride [116,117].
In the case of HR, where both the proton donor
and acceptors are missing, it has been shown that
chloride and azide compete for the same binding
site. The addition of azide resulted in a BR-type
photocycle. The accumulation of intermediate M is
observed [19,82], and transport measurements with
cell envelope vesicles revealed that proton is trans-
ported through the membrane, similarly as for BR
[82]. It was suggested that the bound azide on the EC
side replaces the proton acceptor, while another
azide, shuttling between the Schi¡ base and the cy-
toplasmic surface, plays the role of proton donor.
(b) Mutants. The proton acceptor and donor sites
can be modi¢ed by site-directed mutagenesis. In BR,
when Thr replaced the proton acceptor Asp-85, the
activity of the protein changed from proton to chlo-
ride translocation [81]. Although this BR mutant
transports chloride in the same direction as HR,
from the extracellular side to the cytoplasm, its e⁄-
ciency is very low, in part as a consequence of the
very low chloride a⁄nity of the binding site. This is a
re£ection of the fact that for e⁄cient chloride trans-
port, not only the lack of the proton acceptor is
important, but also the appropriate binding site con-
¢guration, to accommodate the ion. In the case of
HR only very few mutants have been prepared and
no information is available concerning its conversion
to a proton pump in this way.
7. Conclusions
The comparison of di¡erent aspects of the two
ion-pumping proteins, the proton-transporting BR
and the chloride-transporting HR, has demonstrated
interesting similarities and di¡erences. Strikingly,
these two ions, di¡ering fundamentally in size, in
charge and in chemical properties, can be trans-
ported through the membrane via similar steps dur-
ing the photocycle. Unexpectedly, a real equivalence
between the steps could be established by demon-
strating that either protein can transport the ion spe-
ci¢c for the other.
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